Zhexiang Kuang

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Medicine · Health Sciences

3h-index36citations28works1.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(7), Childhood Cancer Survivors' Quality of Life(6), Cancer survivorship and care(4), Hemoglobinopathies and Related Disorders(4), Immune Cell Function and Interaction(4)

Publications28 total

Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemia
Frontiers in Immunology·2026Open Access
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
New England Journal of Medicine·2026· 1 cited
Hetrombopag Added to Cyclosporine as the First‐Line Treatment for Patients With Non‐Severe Aplastic Anemia: A Phase 2 Multicenter Trial
American Journal of Hematology·2026Open Access
A Phase I, open-label study of CTD402, a universal CD7-targeting CAR T-cell therapy, in patients with relapsed/refractory severe aplastic anemia
Blood·2025Open Access
Allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B) for refractory autoimmune hemolytic anemia
Blood·2025
Temporal trends in the disease burden of thalassemia in China from 1990 to 2021 and forecast to 2030
2025Open Access
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
New England Journal of Medicine·2025· 10 cited
Targeting CD38 with daratumumab for platelet transfusion refractoriness in aplastic anemia
Blood·2025· 2 cited
Cost utility analysis of adult patients with severe aplastic anemia: a single-center study
Hematology·2025Open Access
KLRG1 re-defines a leukemic clone of CD8 effector T cells sensitive to PI3K inhibitor in T cell large granular lymphocytic leukemia
Cell Reports Medicine·2025· 2 citedOpen Access
Heterogeneity in Health-Related Quality of Life of Patients with Aplastic Anemia: A Latent Profile Analysis
Patient Preference and Adherence·2025Open Access
Azacitidine in combination with HAG for newly diagnosed and relapsed/refractory AML: a prospective cohort study
Annals of Hematology·2025Open Access
Patient Journey Mapping Enhances Nursing Care in Patients with Hematologic Diseases
Blood·2024
CD19 CAR T-Cell Therapy in Refractory Autoimmune Hemolytic Anemia
Blood·2024· 7 citedOpen Access
Quality of Life after Gene Therapy in Pediatric Patients with Transfusion-Dependent β-Thalassemia and Their Family Caregivers: A Prospective Cohort Study
Blood·2024
Association of Dietary Profiles and Nutritional Status Among Patients with Hematologic Diseases: A Prospective Cohort Study
Blood·2024· 3 cited
Cyclophosphamide Combined with Standard Immunosuppressive Therapy Improves Early Response Outcomes in Severe Aplastic Anemia
Blood·2024
Daratumumab Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia: A Pilot Trail
Blood·2024
Delayed Physical Growth and Related Factors in Pediatric Patients with Transfusion-Dependent Thalassemia
Blood·2024Open Access
Anti-CD38 Monoclonal Antibody Is a Salvage Regimen in Relapsed/Refractory Aplastic Anemia
Blood·2024Open Access
page 1 of 2Next →

Frequent Co-authors

Weiwang Li(12), Xiao Yu(11), Liyun Li(10), Ruonan Li(9), Jun Shi(8), Lele Zhang(7), Liwei Fang(7), Jingyu Zhao(7), Neng Nie(7), Jinbo Huang(7), Lele Zhang(7), Jing Xu(7), Meili Ge(6), Hong Pan(6), Weiping Yuan(6), Liwei Fang(6), Zhen Gao(5), Yizhou Zheng(4), Jing Xu(4), C. F. Xu(4)